Atrogi
Pre-clinicalWe are a phase II ready biotech company pioneering first-in-class treatments to revolutionize metabolic health. Our mission is to redefine the management of muscular wasting and diabetes, and beyond, diseases affecting millions of people globally.
Founded
2018
Focus
Small Molecules
About
We are a phase II ready biotech company pioneering first-in-class treatments to revolutionize metabolic health. Our mission is to redefine the management of muscular wasting and diabetes, and beyond, diseases affecting millions of people globally.
Funding History
1Total raised: $2.5M
Seed$2.5MKarolinska DevelopmentNov 15, 2021
Company Info
TypePrivate
Founded2018
LocationStockholm, Sweden
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile